App

Novavax, a struggling vaccine maker, experienced a significant boost in its stock prices following a new multibillion-dollar deal with French drugmaker Sanofi. The announcement of the licensing agreement resulted in Novavax’s shares nearly doubling, as Wall Street celebrated the partnership that allowed the company to remove its “going concern” warning. Key Details of the Agreement
0 Comments